AcoArt Orchid + AcoArt Dhalia

**AcoArt Orchid + AcoArt Dhalia is a combination medical device consisting of drug-coated balloon catheters indicated for percutaneous transluminal angioplasty (PTA) in patients with obstructive peripheral arterial disease (specifically superficial femoral artery and popliteal artery lesions) and for treating stenotic lesions in dysfunctional native arteriovenous dialysis fistulae. Both items use a lipophilic excipient matrix (magnesium stearate) to deliver paclitaxel, an antiproliferative agent, via proprietary drug-coating technology to the vessel wall, thereby inhibiting neointimal hyperplasia and preventing restenosis. This combination provides an optimized balloon diameter and length range for varying lesion types and complexities, improving clinical outcomes compared to standard balloon angioplasty. Developed by Acotec Scientific, it is a core NMPA-approved product with expanded indications in nephrology (arteriovenous fistula stenosis), neurology (vertebral atherosclerotic stenosis), and andrology (vasculogenic erectile dysfunction).**[1][2][3][4][5][6][7]

Other names

AcoArt Orchid + DhaliaAcoArt Orchid & Dhalia